{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:47:18Z","timestamp":1791830838037,"version":"4.3.4"},"reference-count":26,"publisher":"American Psychiatric Association Publishing","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PS"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1176\/appi.ps.55.8.886","type":"journal-article","created":{"date-parts":[[2004,8,3]],"date-time":"2004-08-03T14:48:18Z","timestamp":1091544498000},"page":"886-891","source":"Crossref","is-referenced-by-count":470,"title":["Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With Schizophrenia"],"prefix":"10.1176","volume":"55","author":[{"given":"Peter J.","family":"Weiden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Kozma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Grogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Locklear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R5581081","doi-asserted-by":"crossref","unstructured":"Olivieri NF, Matsui D, Hermann C, et al: Compliance assessed by the Medication Event Monitoring System. Archives of Disease in Childhood 66:1399\u20131402, 1991","DOI":"10.1136\/adc.66.12.1399"},{"key":"R5581082","unstructured":"Javaid JI, Janicak PG, Holland D: Blood level monitoring of antipsychotics and antidepressants. Psychiatric Medicine 9:163\u2013187, 1991"},{"key":"R5581084","unstructured":"McCombs JS, Nichol MB, Stimmel GL, et al: Use patterns for antipsychotic medications in Medicaid patients with schizophrenia. Journal of Clinical Psychiatry 60(suppl 19):5\u201311, 1999"},{"key":"R5581085","doi-asserted-by":"crossref","unstructured":"Mojtabai R, Lavelle J, Gibson PJ, et al: Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996. Psychiatric Services 53:337\u2013339, 2002","DOI":"10.1176\/appi.ps.53.3.337"},{"key":"R5581086","doi-asserted-by":"crossref","unstructured":"Ayuso-Gutierrez JL, del Rio Vega JM: Factors influencing relapse in the long-term course of schizophrenia. Schizophrenia Research 28:199\u2013206, 1997","DOI":"10.1016\/S0920-9964(97)00131-X"},{"key":"R5581087","unstructured":"Marder SR: Facilitating compliance with antipsychotic medication. Journal of Clinical Psychiatry 59(suppl 3):21\u201325, 1998"},{"key":"R5581088","unstructured":"Weiden PJ, Zygmunt A: The road back: working with the severely mentally ill. Medication noncompliance in schizophrenia: I. assessment. Journal of Practical Psychiatry and Behavioral Health March:106\u2013110, 1997"},{"key":"R5581089","doi-asserted-by":"crossref","unstructured":"Fenton WS, Blyler CR, Heinssen RK: Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin 23:637\u2013651, 1997","DOI":"10.1093\/schbul\/23.4.637"},{"key":"R55810810","doi-asserted-by":"crossref","unstructured":"Robinson D, Woerner MG, Alvir JMJ, et al: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 56:241\u2013247, 1999","DOI":"10.1001\/archpsyc.56.3.241"},{"key":"R55810811","doi-asserted-by":"crossref","unstructured":"Choo PW, Rand CS, Inui TS, et al: Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Medical Care 37:846\u2013857, 1999","DOI":"10.1097\/00005650-199909000-00002"},{"key":"R55810812","doi-asserted-by":"crossref","unstructured":"Farmer KC: Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics 21:1074\u20131090, 1999","DOI":"10.1016\/S0149-2918(99)80026-5"},{"key":"R55810813","doi-asserted-by":"crossref","unstructured":"Maronde RF, Chan LS, Larsen FJ, et al: Underutilization of antihypertensive drugs and associated hospitalization. Medical Care 27:1159\u20131166, 1989","DOI":"10.1097\/00005650-198912000-00007"},{"key":"R55810814","doi-asserted-by":"crossref","unstructured":"Steiner JF, Koepsell TD, Fihn SD, et al: A general method of compliance assessment using centralized pharmacy records: description and validation. Medical Care 26:814\u2013823, 1988","DOI":"10.1097\/00005650-198808000-00007"},{"key":"R55810815","doi-asserted-by":"crossref","unstructured":"Sclar DA, Skaer TL, Chin A, et al: Utility of a transdermal delivery system for antihypertensive therapy: I. American Journal of Medicine 91(suppl 1A):50S-56S, 1991","DOI":"10.1016\/0002-9343(91)90063-4"},{"key":"R55810816","doi-asserted-by":"crossref","unstructured":"Sclar DA, Skaer TL, Chin A, et al: Utility of a transdermal delivery system for antihypertensive therapy: II. American Journal of Medicine 91(suppl 1A):57S-60S, 1991","DOI":"10.1016\/0002-9343(91)90064-5"},{"key":"R55810817","doi-asserted-by":"crossref","unstructured":"Gurwitz JH, Glynn RJ, Monane M, et al: Treatment for glaucoma: adherence by the elderly. American Journal of Public Health 83:711\u2013716, 1993","DOI":"10.2105\/AJPH.83.5.711"},{"key":"R55810818","doi-asserted-by":"crossref","unstructured":"Skaer TL, Sclar DA, Markowski DJ, et al: Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures: a study of patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Pharmacy and Therapeutics 18:295\u2013299, 1993","DOI":"10.1111\/j.1365-2710.1993.tb00591.x"},{"key":"R55810819","doi-asserted-by":"crossref","unstructured":"Monane M, Bohn RL, Gurwitz JH, et al: Non-compliance with congestive heart failure therapy in the elderly. Archives of Internal Medicine 154:433\u2013437, 1994","DOI":"10.1001\/archinte.154.4.433"},{"key":"R55810820","doi-asserted-by":"crossref","unstructured":"McCombs JS, Nichol MB, Newman CM, et al: The costs of interrupting antihypertensive drug therapy in a Medicaid population. Medical Care 32:214\u2013226, 1994","DOI":"10.1097\/00005650-199403000-00003"},{"key":"R55810821","doi-asserted-by":"crossref","unstructured":"Steiner JF, Prochazka AV: The assessment of refill compliance using pharmacy records: methods, validity, and applications. Journal of Clinical Epidemiology 50:105\u2013116, 1997","DOI":"10.1016\/S0895-4356(96)00268-5"},{"key":"R55810822","unstructured":"Hogarty GE: Prevention of relapse in chronic schizophrenic patients. Journal of Clinical Psychiatry 54(3 suppl):18\u201323, 1993"},{"key":"R55810823","doi-asserted-by":"crossref","unstructured":"Valenstein M, Copeland LA, Blow FC, et al: Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care 40:630\u2013639, 2002","DOI":"10.1097\/00005650-200208000-00002"},{"key":"R55810825","doi-asserted-by":"crossref","unstructured":"Gilmer TP, Dolder CR, Lacro JP, et al: Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry 161:692\u2013699, 2004","DOI":"10.1176\/appi.ajp.161.4.692"},{"key":"R55810827","doi-asserted-by":"crossref","unstructured":"Weiden P, Olfson M: Cost of relapse in schizophrenia. Schizophrenia Bulletin 21:419\u2013428, 1995","DOI":"10.1093\/schbul\/21.3.419"},{"key":"R55810828","doi-asserted-by":"crossref","unstructured":"Bright RA, Avorn J, Everitt DE: Medicaid data as a resource for epidemiologic studies: strengths and limitations. Journal of Clinical Epidemiology 42:937\u2013945, 1989","DOI":"10.1016\/0895-4356(89)90158-3"},{"key":"R55810829","doi-asserted-by":"crossref","unstructured":"Iezzoni LI: Assessing quality using administrative data. Annals of Internal Medicine 127(8 pt 2):666\u2013674, 1997","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00048"}],"container-title":["Psychiatric Services"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ps.55.8.886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T19:37:25Z","timestamp":1722368245000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ps.55.8.886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1176\/appi.ps.55.8.886"],"URL":"https:\/\/doi.org\/10.1176\/appi.ps.55.8.886","relation":{},"ISSN":["1075-2730","1557-9700"],"issn-type":[{"value":"1075-2730","type":"print"},{"value":"1557-9700","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}